FDA Clearance Tracker · P130022-S022
Senza Spinal Cord Stimulation (SCS) System
Last checked: Nov 20, 2026Latest source record: Nov 22, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 22, 2019
Approved
Time to decision
235 days
Received Apr 1, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130022-S022
- Device name
- Senza Spinal Cord Stimulation (SCS) System
- Applicant
- Nevro Corporation
- Applicant location
- Redwood City, CA
- Received
- Apr 1, 2019
- Decided
- Nov 22, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P130022
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Integer (dba Greatbatch Medical S. de R.L. de C.V.), Blvd. Hector Teran Teran No. 20120, Ciudad Industrial Tijuana, Baja California, Mexico 22444 for the manufacturing of implantable pulse generators for the Senza Spinal Cord Stimulation (SCS) System.
Source documents
Other decisions for Nevro Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Senza Spinal Cord Stimulation (SCS) SystemPMA supplement
P130022-S042 · Decided Jan 18, 2022 · 180 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.